Damora Therapeutics (DMRA) Other Working Capital Changes (2019 - 2026)
Damora Therapeutics posted quarterly Other Working Capital Changes of -$54000.0 for Q1 2026, down 1700.0% year-on-year from $3375.0 in Q1 2025, and down 107.69% on a QoQ basis from -$26000.0 in Q4 2025.
Damora Therapeutics (DMRA) has 8 years of Other Working Capital Changes data on file, last reported at -$54000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Working Capital Changes fell 1700.0% year-over-year to -$54000.0; the trailing twelve-month figure through Mar 2026 stood at -$71000.0 (up 91.79% YoY), and the FY2025 full-year result was -$20000.0, up 97.9% from the prior year.
- Other Working Capital Changes for Q1 2026 stood at -$54000.0, down from -$26000.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $7.3 million in Q4 2022 and bottomed at -$6.6 million in Q2 2022.
- The 5-year median for Other Working Capital Changes is -$79000.0 (2023), against an average of -$126529.4.
- The widest annual swing landed in 2022, when Other Working Capital Changes plunged 2301.33%; it then soared 625.68% in 2024.
- A 5-year view of Other Working Capital Changes shows it stood at $7.3 million in 2022, then sank by 103.05% to -$222000.0 in 2023, then surged by 625.68% to $1.2 million in 2024, then plunged by 102.23% to -$26000.0 in 2025, then sank by 107.69% to -$54000.0 in 2026.
- The last three Other Working Capital Changes figures came in at -$54000.0 (Q1 2026), -$26000.0 (Q4 2025), and $1000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Damora Therapeutics | 853.36 Mn | 650.97 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -54,000.00 |
| Mar 31, 2026 | -54,000.00 |
| Dec 31, 2025 | -26,000.00 |
| Dec 31, 2025 | -26,000.00 |
| Sep 30, 2025 | 1,000.00 |
| Sep 30, 2025 | 1,000.00 |
| Jun 30, 2025 | 8,000.00 |
| Jun 30, 2025 | 8,000.00 |
| Mar 31, 2025 | -3,000.00 |
| Mar 31, 2025 | -3,000.00 |
| Dec 31, 2024 | 1.17 Mn |
| Dec 31, 2024 | 1.17 Mn |
| Sep 30, 2024 | -1.95 Mn |
| Sep 30, 2024 | -1.95 Mn |
| Jun 30, 2024 | -79,000.00 |
| Jun 30, 2024 | -79,000.00 |
| Mar 31, 2024 | -92,000.00 |
| Mar 31, 2024 | -92,000.00 |
| Dec 31, 2023 | -222,000.00 |
| Dec 31, 2023 | -222,000.00 |
| Sep 30, 2023 | -151,000.00 |
| Sep 30, 2023 | -151,000.00 |
| Jun 30, 2023 | -79,000.00 |
| Jun 30, 2023 | -79,000.00 |
| Mar 31, 2023 | -148,000.00 |
| Mar 31, 2023 | -148,000.00 |
| Dec 31, 2022 | 7.28 Mn |
| Dec 31, 2022 | 7.28 Mn |
| Sep 30, 2022 | -1.06 Mn |
| Sep 30, 2022 | -1.06 Mn |
| Jun 30, 2022 | -6.63 Mn |
| Jun 30, 2022 | -6.63 Mn |
| Mar 31, 2022 | -114,000.00 |
| Mar 31, 2022 | -114,000.00 |
| Dec 31, 2021 | 4.19 Mn |
| Dec 31, 2021 | 4.19 Mn |
| Sep 30, 2021 | -175,000.00 |
| Sep 30, 2021 | -175,000.00 |
| Jun 30, 2021 | 301,000.00 |
| Jun 30, 2021 | 301,000.00 |
| Mar 31, 2021 | -119,000.00 |
| Mar 31, 2021 | -119,000.00 |
| Dec 31, 2020 | -114,000.00 |
| Dec 31, 2020 | -114,000.00 |
| Sep 30, 2020 | 1.46 Mn |
| Sep 30, 2020 | 1.46 Mn |
| Jun 30, 2020 | -1.25 Mn |
| Jun 30, 2020 | -1.25 Mn |
| Mar 31, 2020 | -309,000.00 |
| Mar 31, 2020 | -309,000.00 |
| Dec 31, 2019 | 1.25 Mn |
| Dec 31, 2019 | 1.25 Mn |